Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesWilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia
Cancer, 06/24/09
Renneville A et al. - In a study to determine whether WT1 mutations are a predictor of poor outcome in pts with acute myeloid leukemia (AML), it was reported that WT1 mutations represent an adverse prognostic factor in young adults with AML. Prospective trials should confirm the clinical relevance of WT1 mutations in relation to other prognostic factors in pts with AML.
Methods- 268 young adults (ages 15-50 yrs) with AML who were treated on the Acute Leukemia French Association 9802 trial were studied.
- WT1 exon 7 and 9 mutations were screened retrospectively by polymerase chain reaction and direct sequencing.
- Pts were assessed for presence of the fms-related tyrosine kinase 3 internal tandem duplication (FLT3-ITD), FLT3-D835/I836, nucleophosmin 1 (NPM1), and CCAAT/enhancer binding protein α (CEBPA) mutations.
- WT1 mutations were identified in 14 pts (5%) and were associated with a younger age and an FLT3-ITD.
- No mutation was detected in pts who had favorable cytogenetics.
- Pts who had WT1 mutations had a shorter overall survival at 4 yrs (22% vs 56%) and a higher risk of recurrence at 4 yrs (82% vs 46%) vs pts who had wild-type WT1.
- Within the subgroup of pts who had normal karyotype AML (n=106), WT1 mutation was identified as an independent adverse prognostic factor for risk of recurrence.
Related Articles
Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Relevance Score: 87%%
Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance
Breast Cancer Research and Treatment, 11/04/09
Relevance Score: 86%%
FGFR3 Gene Mutations in Chinese Cases of Thanatophoric Dysplasia Type 1
Fetal Diagnosis and Therapy, 10/21/09
Relevance Score: 81%%
Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/05/09
Relevance Score: 81%%
Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562
Clinical Cancer Research, 10/01/09
Relevance Score: 81%%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients
Cancer, 11/25/09
The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection
Urologic Oncology: Seminars and Original Investigations, 11/25/09
Juxtaglomerular cell tumor of the kidney--a new classification scheme
Urologic Oncology: Seminars and Original Investigations, 11/25/09
Today in Pediatric Nephrology...keeping you current
Receive free subspecialty "5-minute updates" via email
A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure
Nephrology Dialysis Transplantation, 11/25/09
Status quo of percutaneous nephrolithotomy in children
Urological Research - Urolithiasis, 11/25/09
Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents
Pediatric Nephrology, 11/23/09
Article Search
Sponsor